Search Results - "Dougherty, F C"

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease by Locatelli, F, Mann, J F E, Aldigier, J C, Sanz Guajardo, D, Schmidt, R, Van Vlem, B, Sulowicz, W, Dougherty, F C, Beyer, U

“…C.E.R.A., a continuous erythropoietin receptor activator, is a long-acting erythropoiesis-stimulating agent (ESA) that is approved for the treatment of renal…”
Get more information

The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study by Provenzano, R, Besarab, A, Macdougall, I C, Ellison, D H, Maxwell, A P, Sulowicz, W, Klinger, M, Rutkowski, B, Correa-Rotter, R, Dougherty, F C

“…This study was designed to assess the potential of the continuous erythropoietin receptor activator (C.E.R.A.) to correct anemia at extended administration…”
Get more information

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study by de Francisco, A L M, Sulowicz, W, Klinger, M, Niemczyk, S, Vargemezis, V, Metivier, F, Dougherty, F C, Oguey, D

“…This dose-finding, open-label study examined the potential of subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) to correct anaemia at…”
Get more information

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes by Newby, L.K, Bhapkar, M.V, White, H.D, Topol, E.J, Dougherty, F.C, Harrington, R.A, Smith, M.C, Asarch, L.F, Califf, R.M

“…Aims We investigated predictors of 90-day risk among patients surviving the early period after an acute coronary syndrome (ACS). Methods and Results The study…”
Get full text

Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA by Eichstaedt, H W, Felix, R, Dougherty, F C, Langer, M, Rutsch, W, Schmutzler, H

“…We investigated 26 patients admitted to our catheterization laboratory with a diagnosis of acute myocardial infarction. In each case acute revascularization…”
Get more information

Harmonic analysis of perfusion pumps by Dougherty, F Carroll, Donovan, Jr, F M, Townsley, Mary I

“…The controversy over the use of nonpulsatile versus pulsatile pumps for maintenance of normal organ function during ex vivo perfusion has continued for many…”
Get more information

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial by Carrera, Fernando, Lok, Charmaine E., de Francisco, Angel, Locatelli, Francesco, Mann, Johannes F.E., Canaud, Bernard, Kerr, Peter G., Macdougall, Iain C., Besarab, Anatole, Villa, Giuseppe, Kazes, Isabelle, Van Vlem, Bruno, Jolly, Shivinder, Beyer, Ulrich, Dougherty, Frank C.

“…Background. Several studies with erythropoiesis-stimulating agents claim that maintenance therapy of renal anaemia may be possible at extended dosing…”
Get full text

C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis by Roger, Simon D., Locatelli, Francesco, Woitas, Rainer P., Laville, Maurice, Tobe, Sheldon W., Provenzano, Robert, Golper, Thomas A., Ruangkanchanasetr, Prajej, Lee, Ho Yung, Wu, Kwan-Dun, Nowicki, Michal, Ladanyi, Agnes, Martínez-Castelao, Alberto, Beyer, Ulrich, Dougherty, Frank C.

“…Background. No previous randomized controlled studies have been reported examining de novo, once every 4 weeks (Q4W) administration of…”
Get full text

CERA (Continuous Erythropoiesis Receptor Activator): Dose-response, pharmacokinetics and tolerability in phase I multiple ascending dose studies by Dougherty, F. C., Reigner, B., Jordan, P., Pannier, A.

“…Abstract only…”
Get full text

CERA (Continuous Erythropoiesis Receptor Activator): Dose-response, pharmacokinetics and tolerability in phase I multiple ascending dose studies by Dougherty, F. C., Reigner, B., Jordan, P., Pannier, A.

“…Abstract only…”
Get full text

Use of nuclear magnetic resonance imaging to show regression of hypertrophy with ramipril treatment by Eichstädt, Hermann W., Felix, Roland, Langer, Mathias, Gutmann, Monika L., Dougherty, Frank C., Huben, Hermann J., Schmutzler, Horst

“…Thirty-two patients with arterial hypertension (diastolic blood pressure >95 mm Hg) were treated with ramipril for 3 months. The aim of the study was to…”
Get full text

Effects of cimetidine and ranitidine on gastric transmural potential difference and on prolactin secretion in man by von Kleist, D, Gräf, K J, Dougherty, F C, Hampel, K E

“…Endoscopically controlled measurement of gastric mucosal potential differences was performed in 50 subjects receiving ranitidine, cimetidine or normal saline…”
Get more information

Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial by Klinger, Marian, MD, PhD, Arias, Manual, PhD, Vargemezis, Vassilis, MD, Besarab, Anatole, MD, Sulowicz, Wladyslaw, MD, PhD, Gerntholtz, Trevor, FCP (SA), Ciechanowski, Kazimierz, MD, PhD, Dougherty, Frank C., MD, Beyer, Ulrich, PhD

“…Background C.E.R.A. (methoxy polyethylene glycol-epoetin beta), a continuous erythropoietin receptor activator, was developed to provide stable control of…”
Get full text

Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA by Eichstaedt, H W, Felix, R, Danne, O, Dougherty, F C, Schmutzler, H

“…Twenty-six patients admitted to the Free University of Berlin University Hospital catheterization laboratory with acute myocardial infarction were studied. The…”
Get full text

Medical or surgical therapy after percutaneous transluminal coronary recanalization by Schmutzler, H, Rutsch, W, Schartl, M, Dougherty, F C

Get more information

Attenuation of Histamine-Induced Endothelial Permeability Responses after Pacing-Induced Heart Failure: Role for Endogenous Catecholamines by DYESS, DONNA L., HUNTER, J. LESLIE, LAKEY, JAMES R., MOYER, DARLENE, DOUGHERTY, F. CARROLL, TOWNSLEY, MARY I.

“…ABSTRACT Objective: After congestive heart failure (CHF), lung endothelial permeability responses to a number of perturbations, including acute barotrauma,…”
Get full text

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty by Simoons, M L, Arnold, A E, Betriu, A, de Bono, D P, Col, J, Dougherty, F C, von Essen, R, Lambertz, H, Lubsen, J, Meier, B

“…A randomised trial of 367 patients with acute myocardial infarction was performed to determine whether an invasive strategy combining thrombolysis with…”
Get more information